All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Marielle Pitts on perimenopause and anger: fact-checked

Marielle Pitts Functional Medicine NP

Instagram creator

1.2M viewsView on Instagram→

Quick answer

Perimenopause involves fluctuating estrogen levels that can cause mood symptoms including irritability and anger in approximately 45% of women. While hormone therapy may help some symptoms, treatment approaches vary and should be individualized based on symptom severity and personal health factors.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What does this video actually claim?

Marielle Pitts, a functional medicine nurse practitioner, shares her personal perimenopause experience at age 43, describing night sweats, hot flashes, irregular periods, and headaches. She emphasizes psychological symptoms like increased anger and irritability that affected her marriage.

The video appears incomplete, cutting off mid-sentence when discussing how perimenopause "started to affect my marriage." While categorized under TRT, she doesn't explicitly mention testosterone or hormone replacement therapy in the visible portion.

Pitts initially thought her anger was positive self-advocacy but later recognized it as problematic when it created distance in her relationship. The incomplete nature makes it difficult to evaluate her full claims about treatment.

Does the science back up perimenopause mood changes?

Yes, the link between perimenopause and mood symptoms is well-established in research. The Penn Ovarian Aging Study (Freeman et al., Archives of General Psychiatry, 2004) found women were 2.5 times more likely to experience depression during perimenopause compared to premenopause.

The SWAN study (Study of Women's Health Across the Nation) followed 3,302 women and found irritability affected 45% during perimenopause. Anger and mood volatility stem from fluctuating estrogen levels, which affect serotonin and other neurotransmitters.

However, attributing all relationship problems to hormones oversimplifies complex marital dynamics. The Massachusetts Women's Health Study showed that while 23% of perimenopausal women reported mood changes, psychosocial factors like stress and life circumstances played significant roles.

What's missing from this account?

The video lacks important context about perimenopause variability and management options. Pitts presents her experience as typical, but perimenopause symptoms vary dramatically between women.

The North American Menopause Society reports that only 60-80% of women experience vasomotor symptoms like hot flashes. Many women transition through perimenopause without significant mood disruption.

Without seeing the complete video, we can't evaluate what treatments Pitts recommends. The TRT categorization suggests testosterone discussion, but evidence for testosterone therapy in perimenopause remains limited. The Endocrine Society's 2019 guidelines don't recommend routine testosterone for perimenopausal women due to insufficient long-term safety data.

What should you actually know about perimenopause?

Perimenopause typically begins in the mid-40s and lasts 4-8 years before menopause. Estrogen fluctuations during this period can cause mood symptoms, but they're treatable through multiple approaches.

The KEEPS trial (Gleason et al., Menopause, 2015) showed that estrogen therapy can improve mood symptoms when started early in perimenopause. Cognitive behavioral therapy also shows effectiveness, with studies showing 50-73% reduction in hot flash bother scores.

If you're experiencing severe mood changes during perimenopause, don't assume it's just something to endure. The key is distinguishing normal hormonal fluctuations from clinical depression or anxiety that requires professional treatment. A healthcare provider can help determine appropriate interventions based on your specific symptoms and health history.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Marielle Pitts on perimenopause and anger: fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Marielle Pitts on perimenopause and anger: fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Perimenopause involves fluctuating estrogen levels that can cause mood symptoms including irritability and anger in approximately 45% of women.

FormBlends verdict

Perimenopause involves fluctuating estrogen levels that can cause mood symptoms including irritability and anger in approximately 45% of women. While hormone therapy may help some symptoms, treatment approaches vary and should be individualized based on symptom severity and personal health factors.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Perimenopause involves fluctuating estrogen levels that can cause mood symptoms including irritability and anger in approximately 45% of women. While hormone therapy may help some symptoms, treatment approaches vary and should be individualized based on symptom severity and personal health factors.
  • The SWAN study found irritability affects 45% of women during perimenopause due to fluctuating estrogen levels
  • Penn Ovarian Aging Study showed women are 2.5 times more likely to experience depression during perimenopause

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The SWAN study found irritability affects 45% of women during perimenopause due to fluctuating estrogen levels
  • Penn Ovarian Aging Study showed women are 2.5 times more likely to experience depression during perimenopause
  • Vasomotor symptoms like hot flashes affect 60-80% of perimenopausal women according to NAMS data
  • Perimenopause typically begins in the mid-40s and lasts 4-8 years before menopause
  • The KEEPS trial showed early estrogen therapy can improve mood symptoms in some perimenopausal women
  • Endocrine Society guidelines don't recommend routine testosterone therapy for perimenopausal women due to limited safety data
  • Cognitive behavioral therapy shows 50-73% reduction in hot flash severity in clinical studies

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Marielle Pitts Functional Medicine NP · Instagram creator

1.2M views on this video

At 43 perimenopause hit me hard. Not only did I have all the “typical” symptoms of night sweats, hot flashes, period shifts, and headaches BUT I also had more anger, irritability and low libido. It

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Marielle Pitts Functional Medicine NP, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.